Skip to main content
logo
Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
3.550
+0.100 (2.90%)
At close: Oct 6, 2026, 4:00 PM EDT
3.480
-0.070 (-1.97%)
After-hours: Oct 6, 2026, 7:30 PM EDT

Intensity Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
122527117--
Market Cap Growth
-15.62%-7.32%-77.37%---
Enterprise Value
21824102--
Last Close Price
3.5510.2644.00214.25--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.132.089.118.93--
P/TBV Ratio
1.262.089.118.93--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.050.01-0.881.78
Net Debt / Equity Ratio
-1.02-0.99-0.84-1.11-0.62-1.67
Quick Ratio
4.255.561.483.730.191.23
Current Ratio
5.005.921.923.910.211.27
Return on Equity (ROE)
-195.88%-156.90%-202.34%-261.36%--161.84%
Return on Assets (ROA)
-89.91%-79.25%-93.90%-54.58%-135.34%-65.19%
Return on Capital Employed (ROCE)
-123.80%-100.10%-547.70%-62.40%149.20%-535.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-96.31%-47.11%-61.19%-8.97%--
Buyback Yield / Dilution
-273.56%-143.83%-61.40%-152.67%--0.02%
SEC Filings: 10-K · 10-Q